Patents by Inventor Marine BLANCHET

Marine BLANCHET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide derivatives of squalamine for the treatment of infections
    Patent number: 10780101
    Abstract: A compound of formula (I) in which R? represents a group —(CRaRb)n—X—(CRcRd)m—[Y—(CReRf)o]t—NR9R10 and X and Y independently represent a group —NR11-, a group —O— or a divalent 5-membered or 6-membered heterocyclic group comprising at least one nitrogen atom, and also the stereoisomers, mixtures of stereoisomers, and/or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical or veterinary compositions containing the compound of formula (I) and also to the use thereof as medicament, more particularly in the treatment of bacterial, fungal, viral or parasitic infections. Also further disclosed are pharmaceutical or veterinary compositions including the compound of formula (I) in combination with an antibiotic other than such a compound of formula (I).
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: September 22, 2020
    Assignee: VIRBAC
    Inventors: Jean-Michel Brunel, Marine Blanchet, Jean-Pascal Marc
  • AMIDE DERIVATIVES OF SQUALAMINE FOR THE TREATMENT OF INFECTIONS
    Publication number: 20190262362
    Abstract: A compound of formula (I) in which R? represents a group —(CRaRb)n—X—(CRcRd)m—[Y—(CReRf)o]t—NR9R10 and X and Y independently represent a group —NR11-, a group —O— or a divalent 5-membered or 6-membered heterocyclic group comprising at least one nitrogen atom, and also the stereoisomers, mixtures of stereoisomers, and/or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical or veterinary compositions containing the compound of formula (I) and also to the use thereof as medicament, more particularly in the treatment of bacterial, fungal, viral or parasitic infections. Also further disclosed are pharmaceutical or veterinary compositions including the compound of formula (I) in combination with an antibiotic other than such a compound of formula (I).
    Type: Application
    Filed: September 15, 2017
    Publication date: August 29, 2019
    Inventors: Jean-Michel BRUNEL, Marine BLANCHET, Jean-Pascal MARC
  • ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS
    Publication number: 20190255073
    Abstract: A compound of formula (I) in which R? represents a group —(CRaRb)n—X—(CRcRd)m—[Y—(CReRf)o]t—NR9R10 and X and Y independently represent a group —NR11-, a group —O— or a divalent 5-membered or 6-membered heterocyclic group comprising at least one nitrogen atom, and also the stereoisomers, mixtures of stereoisomers, and/or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical or veterinary compositions containing same, which may be used as a medicament, more particularly, in the treatment of bacterial, fungal, viral or parasitic infections. In certain aspects, these pharmaceutical or veterinary compositions include the compound of formula (I) in combination with an antibiotic other than such a compound of formula (I).
    Type: Application
    Filed: September 15, 2017
    Publication date: August 22, 2019
    Applicant: VIRBAC
    Inventors: Jean-Michel BRUNEL, Marine BLANCHET, Jean-Pascal MARC